NICE is planning to slash its budget by 20%. NICE prepares the guidelines of drugs being used for State Health Service.
The move by NICE follows the wishes of Government, according to which the institute should work towards ‘value for money’. This money value under the public spending comes under a system known as value-based drug pricing. This policy will be made public in next two years.
Chief Executive, Andrew Dillon has told that the institute is focusing on saving money, as the government has also decided to spend less on public. He also said that the budget would be reduced in a way so that the output of health technology does not have to compromise in anyway.
Dillon said that the institute won’t shift its focus from the patient access schemes, as these schemes allow the Companies to provide some offers with medicines.
"I'm not quite sure what compromises it might mean in terms of process but we are going to have to make sure we protect the integrity of the way we go about our work”, he said.
A paper published by the Government last week has also said that the institution will publish 150 quality standards for NHS working.
NICE will also give the recommendations about the GP referrals for primary and secondary care. This move will make NICE even the more significant.